Designing compensation plans in pharma is rarely straightforward. What seems fair on paper can sometimes miss the mark in the field, especially when product lifecycles shift or access issues create uneven opportunity. One of the most common challenges we see in pharma incentive compensation planning is overreliance on flat metrics. Quotas that ignore regional complexity or competitive dynamics...